Androgen Deprivation Therapy for Prostate Cancer Associated with Improved Survival in Non Small Cell Lung Cancer: A SEER-MEDICARE Analysis

被引:0
|
作者
Kumar, Mukesh [1 ]
Ragin, Camille [2 ]
Zhang, Chao [1 ]
Chen, Zhengjia [1 ]
Han, Erica J. [1 ]
Ernani, Vinicius [1 ]
Behera, Madhusmita [1 ]
Steuer, Conor [1 ]
Saba, Nabil [1 ]
Shin, Doug [1 ]
Belani, Chandra P. [2 ]
Khuri, Fadlo [1 ]
Ramalingam, Suresh S. [1 ]
Owonikoko, Taofeek K. [1 ]
机构
[1] Emory Univ, Hematol Oncol, Atlanta, GA 30322 USA
[2] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
关键词
Androgen Deprivation Therapy (ADT); NSCLC; Androgen Receptor;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.01-068
引用
收藏
页码:S545 / S545
页数:1
相关论文
共 50 条
  • [21] Trends in Use of Postprostatectomy Therapies for Prostate Cancer: A SEER-Medicare Analysis
    Sheets, N. C.
    Hendrix, L. H.
    Allen, I. M.
    Chen, R. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S544 - S544
  • [22] METFORMIN USE IS ASSOCIATED WITH IMPROVED SURVIVAL IN VETERANS WITH ADVANCED PROSTATE CANCER ON ANDROGEN DEPRIVATION THERAPY
    Richards, Kyle
    Liou, Jinn-ing
    Cryns, Vincent
    Downs, Tracy
    Abel, Jason
    Jarrard, David
    JOURNAL OF UROLOGY, 2017, 197 (04): : E715 - E716
  • [23] Metformin Use is Associated with Improved Survival for Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy
    Richards, Kyle A.
    Liou, Jinn-ing
    Cryns, Vincent L.
    Downs, Tracy M.
    Abel, E. Jason
    Jarrard, David F.
    JOURNAL OF UROLOGY, 2018, 200 (06): : 1256 - 1262
  • [24] Impact Of HIV Infection On Survival In Lung Cancer Patients In The Era Of HAART: A SEER-Medicare Analysis
    Rengan, R.
    Mitra, N.
    Liao, K.
    Armstrong, K.
    Vachani, A.
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (09) : S276 - S277
  • [25] SURVIVAL AND COST OF CARE BY TYPE OF FIRST-LINE THERAPY IN METASTATIC NON-SMALL LUNG CANCER USING SEER-MEDICARE DATA
    Danese, M.
    Lee, A.
    Su, I. H.
    Penrod, J. R.
    Yuan, Y.
    VALUE IN HEALTH, 2024, 27 (06) : S21 - S21
  • [26] A SEER-Medicare analysis of the impact of metformin on overall survival in ovarian cancer
    Garcia, Christine
    Yao, Aaron
    Camacho, Fabian
    Balkrishnan, Rajesh
    Cantrell, Leigh A.
    GYNECOLOGIC ONCOLOGY, 2017, 146 (02) : 346 - 350
  • [27] Prior cancer does not adversely affect survival in locally advanced lung cancer: A national SEER-medicare analysis
    Laccetti, Andrew L.
    Pruitt, Sandi L.
    Xuan, Lei
    Halm, Ethan A.
    Gerber, David E.
    LUNG CANCER, 2016, 98 : 106 - 113
  • [28] ASSOCIATION OF STAGE AT DIAGNOSIS OF NON-SMALL CELL LUNG CANCER WITH OVERALL SURVIVAL AND ONE-YEAR HEALTHCARE EXPENDITURES: AN ANALYSIS OF THE SEER-MEDICARE DATABASE
    Vachani, Anil
    Johnson, Barbara
    Johnston, Stephen
    Johnson, William
    Chandran, Urmila
    Sengupta, Nishan
    Laxmanan, Balaji
    Kalsekar, Iftekhar
    CHEST, 2021, 160 (04) : 1608A - 1609A
  • [29] Disparities in Access to Multidisciplinary Cancer Consultations and Treatment for Patients With Early-Stage Non-Small Cell Lung Cancer: A SEER-Medicare Analysis
    Liu, You-Chi
    Schmidt, Rachel O.
    Kapadia, Nirav S.
    Phillips, Joseph D.
    Moen, Erika L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (01): : 102 - 110
  • [30] Survival impact of newly approved therapeutic agents in patients with advanced non-small cell lung cancer (NSCLC): A SEER-Medicare database analysis.
    Owonikoko, T. K.
    Ramalingam, S. S.
    Behera, M.
    Brandes, J. C.
    Saba, N. F.
    Bhimani, C.
    Harichand-Herdt, S.
    Shin, D. M.
    Khuri, F. R.
    Ragin, C.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)